Metaxx 1.5 mg/ml oral suspension for dogs
Metaxx 1.5 mg/ml oral suspension for dogs
Authorised
- Meloxicam
Product identification
Medicine name:
Metaxx 1.5 mg/ml oral suspension for dogs
Mexxam Vet 1,5 mg/ml Suspension zum Eingeben für Hunde
Active substance:
- Meloxicam
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Meloxicam1.50milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AC06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
Package description:
- 5 ml (in a 10 ml sized bottle). Cardboard box with one HDPE bottle with an LDPE syringe adapter and closed with a polypropylene screw cap. Polypropylene measuring syringe of 3 mL.
- 10 ml. Cardboard box with one HDPE bottle with an LDPE syringe adapter and closed with a polypropylene screw cap. Polypropylene measuring syringe of 3 mL.
- 25 ml. Cardboard box with one HDPE bottle with an LDPE syringe adapter and closed with a polypropylene screw cap. Polypropylene measuring syringe of 3 mL.
- 50 ml. Cardboard box with one HDPE bottle with an LDPE syringe adapter and closed with a polypropylene screw cap. Polypropylene measuring syringe of 3 mL.
- 125 ml. Cardboard box with one HDPE bottle with an LDPE syringe adapter and closed with a polypropylene screw cap. Polypropylene measuring syringe of 3 mL.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Alfasan Nederland B.V.
- Produlab Pharma B.V.
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 842208
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0399/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 20/06/2024
Updated on: 24/02/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 20/06/2024
Updated on: 24/02/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 20/06/2024
Updated on: 24/02/2025
How useful was this page?: